Is insulin resistance a risk factor for the progression of chronic kidney disease?

Kidney and Blood Pressure Research

Volumn 34, Issue 2, 2011, Pages 111-115

  Bastürk, Taner ^a   Unsal, Abdulkadir ^b  

^a Bagcilar Education and Research Hospital ^*  (Turkey)

^b SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Chronic kidney disease; Hypertension; Insulin resistance

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; INSULIN; PARATHYROID HORMONE; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT TOOL; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEINURIA; RENAL REPLACEMENT THERAPY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

AGED; BLOOD PRESSURE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 79551562617     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323904     Document Type: Article

References (19)

1. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J: Insulin resistance in uremia. J Clin Invest 1981;67:563-568. (Pubitemid 11141740)
2. Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, He J: Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 2003;14:469-477. (Pubitemid 36150872)
3. Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE: Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 2002;62:963-970. (Pubitemid 35316726)
4. Knight SF, Imig JD: Obesity, insulin resistance, and renal function. Microcirculation 2007;14:349-362. (Pubitemid 47050027)
5. National Kidney Foundation (K/DOQI): Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002;39:S1-S266.
6. Sit D, Kadiroglu AK, Kayabasi H, Yilmaz ME: The prevalence of insulin resistance in nondiabetic nonobese patients with chronic kidney disease. Adv Ther 2006;23:988-998. (Pubitemid 46341056)
7. Kubo M, Kiyohara Y, Kato I, et al: Effect of hyperinsulinaemia on renal function in a general Japanese population - The Hiyasama Study. Kidney Int 1999;55:2450-2456. (Pubitemid 29256500)
8. Vareesangthip K, Tong P, Wilkinson R, Thomas TH: Insulin resistance in adult polycystic kidney disease. Kidney Int 1997;52:503-508. (Pubitemid 27359596)
9. Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, Titz E: Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998;53:1343-1347. (Pubitemid 28316896)
10. Hjelmesaeth J, Hartmann A: Insulin resistance in patients with adult polycystic kidney disease. Nephrol Dialysis Transplant 1999;14:2521-2522. (Pubitemid 29462508)
11. Kobayashi H, Tokudome G, Hara Y, Sugano N, Endo S, Suetsugu Y, Kuriyama S, Hosoya T: Insulin resistance is a risk factor for the progression of chronic kidney disease. Clin Nephrol 2009;71:643-651.
12. Ikee R, Hamasaki Y, Oka M, Maesato K, Mano T, Moriya H, Ohtake T, Kobayashi S: Glucose metabolism, insulin resistance, and renal pathology in non-diabetic chronic kidney disease. Nephron Clin Pract 2008;108:c163-c168. (Pubitemid 351346941)
13. Mohteshamzadeh M, Wong C, Whiticar R, Thomas S: Is there a link between insulin resistance and chronic kidney disease in men with treated hypertension? Analysis of 5-year data. Am J Nephrol 2009;29:116-122.
14. Satirapoj B, Supasyndh O, Boonyavarakul A, Luesutthiviboon L, Choovichian P: The correlation of insulin resistance and renal function in non-diabetic chronic kidney disease patients. J Med Assoc Thai 2005;883:S97-S104.
15. Yildiz A, Hursit M, Celik AV, Kayacan SM, Yazici H, Akkaya V, Gu AO, Karsidag K: Doxazosin but not amlodipine decrease insulin resistance in patients with chronic renal failure: a prospective, randomized controlled study. Clin Nephrol 2002;58:405-410. (Pubitemid 35446910)
16. Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D, for the MMKD Study: Insulin resistance syndrome, adiponectin and vascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 2005;16:1091-1098. (Pubitemid 41710320)
17. Benson SC, Perhadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, Qi N, Wang J, Avery MA, Kurtz TW: Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR-γ modulating activity. Hypertension 2004;43:993-1002. (Pubitemid 38579904)
18. Matayoshi T, Kamide K, Takiuchi S, et al: Relationship between insulin resistance and the renin-angiotensin system: analysis for patients with essential and renovascular hypertension. Clin Exp Hypertens 2007;29:479-487. (Pubitemid 350125730)
19. De Vinuesa SG, Goicoechea M, Kanter J, et al: Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade. J Am Soc Nephrol 2006;17(suppl 3):S206-S212. (Pubitemid 44865250)